CLINICAL_TRIALS
trial_result
· 2022-12-23
Clinical Trial Update: OTO-313 in Subjects With Subjective Tinnitus [Phase 1, Phase 2]
Summary
Clinical trial update for OTO-313 in subjective tinnitus completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otonomy, Inc. | Conditions: Tinnitus, Subjective | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-12-23